CareRx: Canaccord Raises Price Target To $6.50 Following Financing

Earlier this week, CareRx Corp (TSX: CRRX) closed their C$21.2 million bought deal. Notably, $6.25 million of the proceeds were purchased by Yorkville Asset Management on behalf of existing significant shareholders. Canaccord has since raised their 12-month price target to C$6.50 from C$6 and reiterated their buy rating on the back of the raise.

Tania Gonsalves, Canaccord’s analyst, estimates that with the raise, the company has roughly C$39 million on its balance sheet. She writes, “We believe the current balance sheet is sufficient to fund the SmartMeds Pharmacy Inc. acquisition (pending completion), repay the Yorkville facility next year, and service debt and cash burn until CRRX turns self-funding (expected this year).”

She has also has updated their forecasts to now include the SmartMeds acquisition. SmartMeds is a pharmacy serving over 2,000 people who reside in long-term care, assisted living in Ontario. The purchase price is segmented into three components: $4.0M of upfront cash, ~$0.5M worth of CRRX stock, and an earn-out of up to ~$2.9M in cash payable two years after closing and based on certain milestones.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

She says that the company is expected to add $13 million in revenue and $1.5 million in EBITDA following the close of the transaction. This has increased their EBITDA estimate from C$21.1 million to C$23.3 million.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why I’m Still Bullish on Gold Below $3,900 | Wes Hanson – Thunder Gold

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Echelon Initiates Coverage On Freeman Gold With $1.10 Price Target

Yesterday, Echelon Partners initiated coverage on Freeman Gold Corp (CSE: FMAN) with a C$1.10 12-month...

Wednesday, December 2, 2020, 03:31:00 PM

McDonalds: First Quarter Consensus Estimates

McDonalds Corp (NYSE: MCD) will be reporting their first quarter financials on April 29th before...

Wednesday, April 28, 2021, 05:20:00 PM

BMO Lowers Price Target On Teck Resources To $53 Following BC Weather Events

On December 5th, Teck Resources (TSX: TECK.A) provided an update on the British Columbia weather...

Thursday, December 9, 2021, 10:09:00 AM

Kinross Gold: BMO Lifts Price Target On Chirano Mine Sale

Yesterday, Kinross Gold (TSX: K) announced the sale of its Chirano mine in Ghana. The...

Tuesday, April 26, 2022, 03:46:00 PM

Beyond Meat: Analysts Lower Price Targets Following Disappointing Earnings

Beyond Meat (NASDAQ: BYND) has been a laggard this year, with its year-to-date performance currently...

Sunday, May 16, 2021, 02:13:00 PM